Charles River Laboratories International (CRL) Change in Accured Expenses (2009 - 2025)

Charles River Laboratories International (CRL) has reported Change in Accured Expenses for 17 consecutive years, with -$2.6 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Change in Accured Expenses rose 90.0% year-over-year to -$2.6 million; the TTM figure through Dec 2025 stood at $79.3 million (up 387.31% YoY), while the FY2025 annual figure was $79.3 million, up 387.31% from the prior year.
• Change in Accured Expenses came in at -$2.6 million for Q4 2025 at Charles River Laboratories International, down from $42.9 million in the prior quarter.
• The five-year high for Change in Accured Expenses was $51.3 million in Q2 2021, with the low at -$79.8 million in Q1 2022.
• Average Change in Accured Expenses over 5 years is $3.3 million, with a median of $4.9 million recorded in 2021.
• Across the five-year window, Change in Accured Expenses surged 563.47% in 2023 and sank 188.33% in 2024, its largest moves.
• Year by year, Change in Accured Expenses stood at $26.1 million in 2021, then slumped by 136.14% to -$9.4 million in 2022, then tumbled by 69.58% to -$16.0 million in 2023, then sank by 60.23% to -$25.6 million in 2024, then surged by 90.0% to -$2.6 million in 2025.
• According to Business Quant data, Change in Accured Expenses over the past three periods registered -$2.6 million, $42.9 million, and $23.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.